Saturday, April 20, 2024 4/20/2024

SC-Links - Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease Care

Award Number: U01HL134007
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Project Summary This proposal establishes a formal collaborative consortium, SC-Links, that addresses NHLBI's strategic plan goal to foster improved understanding of the processes involved in translating research into practice for youth and adults with sickle cell disease (SCD) in the U.S. This population has faced long-standing and pervasive inequities in accessing preventive care with outpatient providers who are knowledgeable about SCD, and with accessing consistent, high quality care when seeking treatment in the emergency department (ED) for severe pain. The consortium brings together the expertise of SCD clinical and health services researchers, implementation scientists and a range of stakeholders, in multi-level interventions that target individuals, providers, healthcare systems and communities with the specific aims to: 1a) Establish a common framework of the problem of SCD care in the region, consider strategies to adapt evidence-based interventions for meeting unique patient and provider needs and propose feasible healthcare infrastructure enhancements that can help routinize preventive care for youth and adults ages 15 – 45 years with SCD; 1b) Engage the larger SCD stakeholder community in a mixed methods needs assessment to identify facilitators and barriers to preventive and acute SCD care and effective patient self-management; and enroll patients in the SCD registry; 2) Establish a population-based SCD Registry and recruit a minimum of 300 youth and adults in a five county area (representing important variations in care) in N. California. This cohort will be enrolled in interventions in Phase II of SC-Links; and 3) Implement and evaluate the impact of the SC-Links intervention components including: improving operations within SCD and primary care delivery settings to ensure that patients receive health maintenance and hydroxyurea monitoring according to the NHLBI guidelines; introducing evidence- based health coaching to engage patients, identified through the registry, as in need of primary or SCD outpatient care; and implementing a standard order set in participating EDs to improve timely assessment and treatment of acute SCD-related pain. The target population for these interventions is 605 youth and adults with SCD in the region. The research uses evidence-based models not previously applied to SCD research, to inform understanding of barriers/enablers to shape intervention components and to assess population health measures such as effectiveness at reaching a wide range of clinical sites and representativeness of the registry sample. The project draws on a newly established statewide longitudinal SCD surveillance system and incorporates measurement that is harmonized across studies. The research uses the highest level of randomization feasible, including the novel stepped-wedge cluster study design to introduce standard order sets for SCD pain in the ED. By using established and innovative approaches to theory, measurement and research design, the project advances scientific knowledge of the best methods to promote clinical practice changes to lessen the gap between the evidence base and appropriate treatment and preventive SCD care.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Blood Diseases and Resources Research	000	6	8/1/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = -$37,102 )
2022	2021	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Blood Diseases and Resources Research	000	6	11/6/2021	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$37,102
2022	2021	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Blood Diseases and Resources Research	002	6	11/28/2021	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$574,440
2022	2020	CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND	747 52ND ST	OAKLAND	CA	94609	ALAMEDA	USA	Blood Diseases and Resources Research	001	5	11/28/2021	NON-COMPETING CONTINUATION	-$574,440
														Subtotal = -$37,102

Issue Date FY: 2021 ( Subtotal = $596,672 )
2021	2021	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94143	SAN FRANCISCO	USA	Blood Diseases and Resources Research	001	6	8/14/2021	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$596,672
2021	2020	CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND	747 52ND ST	OAKLAND	CA	94609	ALAMEDA	USA	Blood Diseases and Resources Research	000	5	8/13/2021	NON-COMPETING CONTINUATION	$0
														Subtotal = $596,672

Issue Date FY: 2020 ( Subtotal = $587,250 )
2020	2020	CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND	747 52ND ST	OAKLAND	CA	94609	ALAMEDA	USA	Blood Diseases and Resources Research	000	5	6/17/2020	NON-COMPETING CONTINUATION	$587,250
														Subtotal = $587,250

Issue Date FY: 2019 ( Subtotal = $820,293 )
2019	2019	CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND	747 52ND ST	OAKLAND	CA	94609	ALAMEDA	USA	Blood Diseases and Resources Research	000	4	6/13/2019	NON-COMPETING CONTINUATION	$820,293
														Subtotal = $820,293

Issue Date FY: 2018 ( Subtotal = $832,271 )
2018	2018	CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND	747 52ND ST	OAKLAND	CA	94609	ALAMEDA	USA	Blood Diseases and Resources Research	000	3	6/16/2018	NON-COMPETING CONTINUATION	$832,271
														Subtotal = $832,271

Issue Date FY: 2017 ( Subtotal = $615,512 )
2017	2017	CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND	747 52ND ST	OAKLAND	CA	94609	ALAMEDA	USA	Blood Diseases and Resources Research	000	2	6/30/2017	NON-COMPETING CONTINUATION	$615,512
														Subtotal = $615,512

Issue Date FY: 2016 ( Subtotal = $655,656 )
2016	2016	CHILDRENS HOSP. & RESEARCH CTR OF OAKLAND	747 52ND STREET	OAKLAND	CA	94609	ALAMEDA	USA	Blood Diseases and Resources Research	000	1	8/4/2016	NEW	$655,656
														Subtotal = $655,656

Grand Total All Awards = $4,070,552

Top

All Categories

About

Search

Reports

Data Submission

Award Information

SC-Links - Linking the Sickle Cell Community, Providers and Systems to Improve Sickle Cell Disease Care

Award Number: U01HL134007

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer